BC3/Breast Cancer Coordinated Care

Friday, November 8, 2024, 12:00 PM - Sunday, November 10, 2024, 5:00 PM, Leon & Norma Hess Center for Science and Medicine, Davis Auditorium, 1470 Madison Avenue, New York, NY


This is a multidisciplinary course to discuss controversies and cutting edge treatments in the management of breast cancer. It will include breast surgeons, plastic and reconstructive surgeons, oncologists, radiologists, physical therapists, and others. Speakers will focus on novel topics in diagnosis and management.

1. Describe neoadjuvant and adjuvant therapies for triple negative breast cancer
2. Identify appropriate screening for breast cancer in transgender patients
3. Explain to patients the management of side effects of breast cancer treatment
4. Describe the options for management of a positive sentinel lymph node biopsy
5. Identify current indications for radiation and its role in de-escalating surgical treatment
6. Explain to practitioners the multi-disciplinary management of lymphedema

* Early Bird Fees expire September 20th*

Early Bird Physicians - $799.00
Early Bird Physician Assistant - $519.00
Early Bird NP/RN - $519.00
Early Bird Allied Health Professional - $519.00
Early Bird PT/OT - $519.00
Early Bird Resident/Fellow - $100.00
Medical Students - $25.00
Industry - $1,000.00

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (18.00 hours), Non-Physician Attendance (18.00 hours)

You are not logged in.

Please click the button below to login or create a new account before continuing.

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose all their financial relationships with ineligible companies within the prior 24 months. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material. Relevant financial relationships will be mitigated and disclosed to learners before the activity takes place.